In their study, they determined that MMP-9 expression was best estimated by Kep, of all perfusion parameters, and demonstrated an association with survival, suggesting Kep as a potential imaging biomarker of GBM progression and its prognostication (27). This evidence concerns the gene PCSK1N and glioblastoma.